Phase II Study DCVAC/OvCa Plus Carboplatin Gemcitabine Relapsed Platinum (Pt)-Sensitive Epithelial Ovarian Carcinoma

NCT02107950 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

71

Enrollment

INDUSTRY

Sponsor class

Conditions

Ovarian Neoplasms
Ovarian Cancer (OvCa)
Ovarian Epithelial Cancer

Interventions

BIOLOGICAL: DCVAC/OvCa in parallel with chemotherapy
DRUG: Standard of Care

Sponsor

SOTIO a.s.